HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuru Ohsugi Selected Research

Liraglutide

8/2020Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist: A case report.
1/2012The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuru Ohsugi Research Topics

Disease

12Type 2 Diabetes Mellitus (MODY)
07/2022 - 06/2006
11Insulin Resistance
01/2019 - 02/2005
5Insulinoma
07/2019 - 10/2002
5Obesity
01/2019 - 02/2005
5Glucose Intolerance
11/2014 - 06/2006
3Inflammation (Inflammations)
04/2012 - 04/2011
3Body Weight (Weight, Body)
01/2012 - 04/2007
2Diabetes Complications
07/2022 - 07/2019
2COVID-19
06/2022 - 06/2022
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2020 - 08/2020
2Non-alcoholic Fatty Liver Disease
01/2019 - 01/2012
1Hemiplegia (Spastic Hemiplegia)
02/2022
1Reperfusion Injury
02/2022
1Hypoglycemia (Reactive Hypoglycemia)
02/2022
1Hypercholesterolemia
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Renal cysts and diabetes syndrome
08/2020
1Nausea
08/2020
1Albuminuria
01/2020
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2020
1Lymphopenia (Lymphocytopenia)
07/2019
1Wilms Tumor (Wilm's Tumor)
01/2018
1Diabetes Mellitus
04/2014
1Coronary Artery Disease (Coronary Atherosclerosis)
03/2012
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2012
1Hypertrophy
10/2002

Drug/Important Bio-Agent (IBA)

13Insulin (Novolin)FDA Link
07/2022 - 06/2004
13Glucose (Dextrose)FDA LinkGeneric
06/2022 - 10/2002
3AdiponectinIBA
04/2011 - 04/2007
2Hypoglycemic Agents (Hypoglycemics)IBA
07/2022 - 02/2020
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
06/2022 - 01/2020
2Blood Glucose (Blood Sugar)IBA
06/2022 - 08/2020
2LiraglutideFDA Link
08/2020 - 01/2012
2Triglycerides (Triacylglycerol)IBA
01/2019 - 02/2005
2Sitagliptin Phosphate (Januvia)FDA Link
01/2017 - 01/2012
2Insulin ReceptorIBA
04/2011 - 02/2005
2Phosphotransferases (Kinase)IBA
04/2011 - 10/2002
2EnzymesIBA
06/2006 - 02/2005
2Insulin Receptor Substrate ProteinsIBA
06/2006 - 02/2005
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Insulin Glargine (Lantus)FDA Link
08/2020
1Glucagon-Like Peptide-1 ReceptorIBA
08/2020
1Metformin (Glucophage)FDA LinkGeneric
02/2020
1BiguanidesIBA
02/2020
1Advanced Glycation End ProductsIBA
07/2019
1AntigensIBA
07/2019
1AutoantibodiesIBA
07/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2018
1MethyltransferasesIBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2018
1glimepiride (Amarel)FDA LinkGeneric
01/2017
1C-PeptideIBA
11/2014
1Fatty Acids (Saturated Fatty Acids)IBA
04/2012
1Pioglitazone (Actos)FDA Link
01/2012
1ChemokinesIBA
04/2011
1Class Ia Phosphatidylinositol 3-KinaseIBA
12/2010
1AMP-Activated Protein KinasesIBA
01/2009
1RimonabantIBA
01/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2007
1AntibodiesIBA
06/2007
1N-acetyltalosaminuronic acid (NAT)IBA
04/2007
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2006
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2006
1U 0126 (UO 126)IBA
09/2006
1Glycogen Synthase (Synthase I)IBA
04/2005
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
04/2005
1Small Interfering RNA (siRNA)IBA
02/2005
1Acyl Coenzyme A (Acyl CoA)IBA
02/2005
1Diacylglycerol O-AcyltransferaseIBA
02/2005
1LeptinIBA
02/2005
1Complementary DNA (cDNA)IBA
06/2004
1Protein Kinases (Protein Kinase)IBA
10/2002

Therapy/Procedure

3Glycemic Control
06/2022 - 07/2019
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2012
1Percutaneous Coronary Intervention
03/2012